Roche Diagnostics Moritz Hartmann, Middle East General Manager of Roche Diagnostics, gives his insight on why Roche Diagnostics made the decision to set up shop in Dubai, what the main challengers in a developing market were and will be, and why the government has been so supportive of the company’s endeavors thus…
diabetes Christine Marie D. Rosal, Country Manager of Novo Nordisk Pharmaceuticals (Philippines) gives a startling image of the current state of diabetes in the Philippines, the major reasons behind the soaring rates of diabetes and what the government along with companies such as Novo Nordisk can do to prevent a worsening…
Abnova Chairman of Abnova Corporation Wilber Huang discusses the company’s core strengths, Taiwan’s bilateral relationship with China’s biotech industry, and offers some advice to future start-up biotech companies in Taiwan. Abnova was founded during a very exciting time in the biotech industry. Can you tell us a bit more about what…
Biosimilars Jim Keon, Preisdent of CGPA, discusses the cost-saving benefits that generic drugs have offered Canada, and offers his insights into Canada’s intellectual property regime and the challenges of pricing in Canada. As a privileged witness to the evolution of the Canadian generic industry, what have been some of the defining…
Dialysis The general manager of Baxter in the Nordic region discusses the concept of home care, and how brand new technologies currently being tested in Sweden should mean that soon, dialysis treatment will shift from the hospital to the home around the world. Could you please give us a brief introduction…
diabetes Carlos Manuel González Parra discusses the progress Novo Nordisk has made as a newcomer to the Colombian market and its hopes and intentions for the future. One of the main focuses is in manoeuvring Novo Nordisk Colombia into a position where they will be a key player in the diabetes…
Aepodia Having worked in internal clinical research for Eli Lilly for 14 years, from 1993 – 2007, what has this experience taught you about what pharmaceutical companies need in an outsourcing partner, and how does Aepodia respond to those needs? What we have seen is a transformation in the pharmaceutical industry.…
Mexican Diabetes Federation Could you give us a brief introduction to the Federacion Mexicana de Diabetes? The Mexican Diabetes Federation was established in 1988 by a group of people affected by diabetes, as well as families and health professionals interested in tackling this disease in a more effective and preventive way Nowadays our…
Zodiac Pharmaceuticals What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D capabilities. I personally think that the country can’t build a strong pharmaceutical industry based only on generics. Generics are an important part of the…
UCB India You have only recently been appointed Managing Director for the first time in your career. How did your first year with UCB India go so far? My first year at UCB has gone very well. Our business has grown in this period ahead of the Pharma market in India. My…
Novo Nordisk India Private Limited Novo Nordisk seems somewhat of an exception to the MNCs that recently entered India, as it already set up its HQ in Bangalore in 1994. How do you explain this relatively early entry? Traditionally, Novo Nordisk’s strategy has been to be in the market very early. We aspire to create…
See our Cookie Privacy Policy Here
